Molecular Docking Studies of Berberine Derivative as Novel Multitarget PCSK9 and HMGCR Inhibitors. Sci. Ess. J. 2021;37(1):124-142. Accessed October 23, 2026. https://ejournals.swu.ac.th/sej/article/view/13502